Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway

BMC Complementary and Alternative Medicine

Xiaochun Chen¹  Yuangui Zhu¹  Xiaodong Zhang¹  Bixia Huang¹  Xianjie Xu¹  Linfeng Ye¹  Qinyong Ye¹ 

[1] Department of Neurology, Fujian Institute of Geriatrics, The Affiliated Union Hospital of Fujian Medical University, 29 Xinquan Road, Fuzhou, Fujian, 350001, China

关键词: SIRT1;    PGC-1α;    PC12 cells;    (−)-epigallocatechin-3-gallate;    Parkinson’s disease;   

Others  :  1232133
DOI  :  10.1186/1472-6882-12-82

 received in 2011-12-04, accepted in 2012-06-28,  发布年份 2012

【 摘 要 】

Background

Parkinson’s disease is a high incidence neurodegenerative disease in elderly people, and oxidative stress plays an important role in the pathogenesis. Oxygen metabolism in the brain is high, which lacks an antioxidative protection mechanism. Recently, it has been found that polyphenols play an important role in antioxidation. (−)-epigallocatechin-3-gallate (EGCG) is an important component of tea polyphenols and its biological effects, such as strong antioxidation, scavenging of free radicals and anti-apoptosis, can pass through the blood brain barrier. The SIRT1/PGC-1α signaling pathway has not been reported in PC12 cells. Therefore, research of the protective mechanism of EGCG in PC12 cells damaged by -methyl-4-phenyl-pyridine (MMP⁺) may provide a new insight into protect against and treatment of Parkinson’s disease.

Methods

MPP⁺-treated highly differentiated PC12 cells were used as the in vitro cell model. An MTT assay was used to investigate cell viability after EGCG treatment, a dichlorofluorescin diacetate assay was used to measure reactive oxygen species (ROS) production, western blot analysis was used to observe PGC-1α and SIRT1 protein expression, and real-time PCR to observe PGC-1α, SOD1 and GPX1 mRNA expression.

Results

PC12 cell viability was significantly reduced after MPP⁺ treatment by 11.46% compared with that of the control (P < 0.05). However, cell viability was unchanged by 10 μmol/L EGCG treatment. In co-treatments with EGCG and MPP⁺, cell viability was significantly increased by 12.92% (P < 0.05) and MPP⁺-induced ROS production was markedly decreased. PGC-1α mRNA expression was obviously upregulated by 21.51% (P < 0.05), and SOD1 and GPX1 mRNA expression was slightly increased by 12.94% and 15.63% (P > 0.05), respectively, by treatment with EGCG and then MPP⁺ for 12 h. The mRNA expression of PGC-1α, SOD1 and GPX1 was increased by 25.17%, 40% and 146% (all P < 0.05), respectively, by treatment with EGCG and then MPP⁺ for 24 h. Such effects were not observed with MPP⁺ treatment alone.

Conclusion

The SIRT1/PGC-1α pathway is one of the mechanisms of EGCG suppression of MPP⁺-induced injury of PC12 cells.

【 授权许可】

   
2012 Ye et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Mukhtar H, Ahmad N: Tea polypphenols: prevention of cancer and optimizing health. Am J Clin Nutr 2000, 71:1698-1702.
• [2]Huo C, Wan SB, Lam WH, Li L, Wang Z, Landis-Piwowar KR, Chen D, Dou QP, Chan TH: The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology 2008, 16:248-252.
• [3]Beal MF: Mitochondria, oxidative damage, and inflammation in Parkinson’s disease. Ann NY Acad Sci 2003, 991:120-131.
• [4]Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5’––3’ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991, 88:7276-7280.
• [5]Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 2001, 25:402-408.
• [6]Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB: Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 2008, 138:1578-1583.
• [7]Weinreb O, Mandel S, Amit T, Youdim MB: Neurological mechanisms of green tea polyphenols in Alzheimer′s disease and Parkinson's diseases. J Nutr Biochem 2004, 15:506-516.
• [8]Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP: A novel prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 2007, 67:4303-4310.
• [9]Coentrão Pde A, Teixeira VL, Netto AD: Antioxidant activity of polyphenols from green and toasted mate tea. Nat Prod Commun 2011, 6:651-656.
• [10]Lotharius J, O’Malley KL: The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation.A novel mechanism of toxicity. J Biol Chem 2000, 275:38581-38588.
• [11]Obata T: Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping. Toxicol Lett 2002, 132:83-93.
• [12]Shafer TJ, Atchison WD: Transmitter, ion channel and receptor properties of pheochromocytoma(PC12)cells: a model for neurotoxicological studies. Neurotoxicology 1991, 12:473-492.
• [13]Mandel S, Reznichenko L, Amit T, Youdim MB: Green tea polyphenol(−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway. Neurotox Res 2003, 5:419-424.
• [14]Puigserver P, Spiegelman BM: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha(PGC-1alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 2003, 24:78-90.
• [15]St-Pierre J, Drori S, Uldry M, et al.: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
• [16]Gerhart-Hines Z, Rodgers JT, Bare O, et al.: Metabolic control of mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007, 26:1913-1923.